None listed
Conditions
Interventions
Medical Device : Participants in this study are randomly assigned to ClearHemograsper (by Finemedics in Korea) and Coagrasper (by Olympus in Japan) with a probability of 50% according to a random numb
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosed as adenoma or early gastric cancer and meets the indications for endoscopic resection 2. Where he/she voluntarily signed a written informed consent form after hearing an explanation of the purpose, method, effect, etc. of the study
Exclusion criteria
Exclusion criteria: 1. Women of childbearing potential who are unable to use adequate contraception or are pregnant or lactating 2. Past history of gastrectomy 3. When endoscopic resection cannot be safely performed due to hemorrhagic disease or coagulation disorder 4. When the investigator determines that endoscopic resection is impossible 5. Who do not understand the purpose of the study or do not consent to the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total time required to hemostasis for all bleeding events during endoscopic submucosal dissection (seconds) ;Abdominal pain, bleeding, or infection after the procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction of operators and assistants regarding hemostasis | — |
Countries
Korea, Republic of
Contacts
Public ContactJin Hee Noh
Asan Medical Center
Outcome results
None listed